Literature DB >> 17925573

PI3K class IB pathway.

Simon Andrews1, Len R Stephens, Phillip T Hawkins.   

Abstract

Class I phosphoinositide 3-kinases (PI3Ks) are well-established signal transduction enzymes that play an important role in the mechanisms by which a wide variety of cell surface receptors control several cellular functions, including cellular growth, division, survival, and movement. Class IB PI3K (also known as PI3Kgamma) allows fast-acting, heterotrimeric GTP-binding protein-coupled receptors to access this pathway. Activation of class IB PI3K results in the rapid synthesis of phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] and its dephosphorylation product, PI(3,4)P2, in the plasma membrane. These two lipid messengers bind to multiple, pleckstrin homology (PH) domain-containing effectors, which together regulate a complex signaling web downstream of receptor activation. This pathway regulates the activity of protein kinases and small guanosine triphosphatases that control cellular movement, adhesion, contraction, and secretion. Most of the ligands that have been established to activate class IB PI3K are involved in coordinating the body's response to injury and infection through the regulation of multiple cell types in the immune system and vascular lining. Mice lacking the catalytic subunit of class IB PI3K are remarkably resistant to the development of several inflammatory pathologies in mouse models of human inflammatory disease. These results suggest small molecule inhibitors of class IB PI3K may represent a novel class of therapeutic agents that may complement existing anti-inflammatory treatments.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17925573     DOI: 10.1126/stke.4072007cm2

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  9 in total

1.  Involvement of phosphoinositide 3-kinase and PTEN protein in mechanism of activation of TRPC6 protein in vascular smooth muscle cells.

Authors:  Michaël Monet; Nancy Francoeur; Guylain Boulay
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

2.  Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer.

Authors:  Maria Soledad Sosa; Cynthia Lopez-Haber; Chengfeng Yang; Hongbin Wang; Mark A Lemmon; John M Busillo; Jiansong Luo; Jeffrey L Benovic; Andres Klein-Szanto; Hiroshi Yagi; J Silvio Gutkind; Ramon E Parsons; Marcelo G Kazanietz
Journal:  Mol Cell       Date:  2010-12-22       Impact factor: 17.970

3.  Gemfibrozil, a lipid-lowering drug, induces suppressor of cytokine signaling 3 in glial cells: implications for neurodegenerative disorders.

Authors:  Arunava Ghosh; Kalipada Pahan
Journal:  J Biol Chem       Date:  2012-06-08       Impact factor: 5.157

4.  Structural effects of morpholine replacement in ZSTK474 on Class I PI3K isoform inhibition: Development of novel MEK/PI3K bifunctional inhibitors.

Authors:  Marcian E Van Dort; Youngsoon Jang; Christopher A Bonham; Kevin Heist; Dilrukshika S W Palagama; Lucas McDonald; Edward Z Zhang; Thomas L Chenevert; Gary D Luker; Brian D Ross
Journal:  Eur J Med Chem       Date:  2021-11-14       Impact factor: 6.514

Review 5.  PI3K signaling in glioma--animal models and therapeutic challenges.

Authors:  Christine K Cheng; Qi-Wen Fan; William A Weiss
Journal:  Brain Pathol       Date:  2009-01       Impact factor: 6.508

Review 6.  PI3K Signaling in Normal B Cells and Chronic Lymphocytic Leukemia (CLL).

Authors:  Klaus Okkenhaug; Jan A Burger
Journal:  Curr Top Microbiol Immunol       Date:  2016       Impact factor: 4.291

7.  Noncanonical regulation of insulin-mediated ERK activation by phosphoinositide 3-kinase γ.

Authors:  Maradumane L Mohan; Arunachal Chatterjee; Swetha Ganapathy; Sromona Mukherjee; Sowmya Srikanthan; George P Jolly; Rohit S Anand; Sathyamangla V Naga Prasad
Journal:  Mol Biol Cell       Date:  2017-09-06       Impact factor: 4.138

Review 8.  Signaling by the phosphoinositide 3-kinase family in immune cells.

Authors:  Klaus Okkenhaug
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527

9.  Seizure-induced reduction in PIP3 levels contributes to seizure-activity and is rescued by valproic acid.

Authors:  Pishan Chang; Matthew C Walker; Robin S B Williams
Journal:  Neurobiol Dis       Date:  2013-10-19       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.